blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2344632

EP2344632 - METHOD FOR INDUCING PLURIPOTENCY IN CELLS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.11.2023
Database last updated on 13.09.2024
FormerThe patent has been granted
Status updated on  25.11.2022
FormerGrant of patent is intended
Status updated on  10.07.2022
FormerExamination is in progress
Status updated on  18.11.2016
Most recent event   Tooltip07.06.2024Lapse of the patent in a contracting state
New state(s): MC		published on 10.07.2024  [2024/28]
Applicant(s)For all designated states
Minerva Biotechnologies Corporation
40 Bear Hill Rd.
Waltham, MA 02451 / US
[2023/14]
Former [2022/52]For all designated states
Minerva Biotechnologies Corporation
40 Bear Hill Rd.
Waltham, MA 02451 / US
For all designated states
Bamdad, Cynthia
356 Marlborough, Unit 2
Boston, MA 02115 / US
Former [2011/29]For all designated states
Minerva Biotechnologies Corporation
40 Bear Hill Rd.
Waltham, MA 02451 / US
For all designated states
Bamdad, Cynthia C.
356 Marlborough, Unit 2
Boston, Massachusetts 02115 / US
Inventor(s)01 / BAMDAD, Cynthia
356 Marlborough, Unit 2
Boston, MA 02115 / US
02 / FESSLER, Shawn
6 Twin Circle Drive
Arlington, MA 02474 / US
 [2011/29]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2022/52]
Former [2011/29]Cowley, Catherine Mary, et al
Venner Shipley LLP, 20 Little Britain
London EC1A 7DH / GB
Application number, filing date09820001.709.10.2009
[2011/29]
WO2009US60272
Priority number, dateUS20080104231P09.10.2008         Original published format: US 104231 P
[2011/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010042891
Date:15.04.2010
Language:EN
[2010/15]
Type: A2 Application without search report 
No.:EP2344632
Date:20.07.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 15.04.2010 takes the place of the publication of the European patent application.
[2011/29]
Type: B1 Patent specification 
No.:EP2344632
Date:28.12.2022
Language:EN
[2022/52]
Search report(s)International search report - published on:US27.12.2012
(Supplementary) European search report - dispatched on:EP11.10.2013
ClassificationIPC:A61K38/48, C12N5/071
[2013/46]
CPC:
C12N5/0606 (EP,KR,US); C07K14/47 (KR); C12N15/63 (KR);
C12N5/00 (KR); C12N5/0696 (EP,KR,US); C12N2501/40 (EP,KR,US);
C12N2501/50 (EP,KR,US); C12N2501/602 (EP,KR,US); C12N2501/603 (EP,KR,US);
C12N2501/604 (EP,KR,US); C12N2501/998 (EP,KR,US) (-)
Former IPC [2013/32]A61K38/48
Former IPC [2011/29]C12N5/071, C12N5/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2022/52]
Former [2011/29]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:VERFAHREN ZUR HERBEIFÜHRUNG VON PLURIPOTENZEN IN ZELLEN[2011/29]
English:METHOD FOR INDUCING PLURIPOTENCY IN CELLS[2011/29]
French:PROCÉDÉ PERMETTANT D'INDUIRE UNE PLURIPOTENCE DANS DES CELLULES[2011/29]
Entry into regional phase26.04.2011National basic fee paid 
26.04.2011Search fee paid 
26.04.2011Designation fee(s) paid 
26.04.2011Examination fee paid 
Examination procedure26.04.2011Examination requested  [2011/29]
02.05.2014Amendment by applicant (claims and/or description)
14.07.2016Despatch of a communication from the examining division (Time limit: M06)
28.04.2017Reply to a communication from the examining division
15.01.2018Despatch of a communication from the examining division (Time limit: M04)
27.03.2018Reply to a communication from the examining division
18.04.2018Observations by third parties
28.09.2018Despatch of a communication from the examining division (Time limit: M06)
18.07.2019Reply to a communication from the examining division
23.04.2020Despatch of a communication from the examining division (Time limit: M06)
25.11.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
27.01.2021Reply to a communication from the examining division
11.07.2022Communication of intention to grant the patent
17.11.2022Fee for grant paid
17.11.2022Fee for publishing/printing paid
17.11.2022Receipt of the translation of the claim(s)
Divisional application(s)EP22209455.9  / EP4201421
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.07.2016
Opposition(s)29.09.2023No opposition filed within time limit [2023/49]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
27.01.2021Request for further processing filed
27.01.2021Full payment received (date of receipt of payment)
Request granted
03.02.2021Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
18.07.2019Request for further processing filed
18.07.2019Full payment received (date of receipt of payment)
Request granted
29.07.2019Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
28.04.2017Request for further processing filed
28.04.2017Full payment received (date of receipt of payment)
Request granted
16.05.2017Decision despatched
Fees paidRenewal fee
31.10.2011Renewal fee patent year 03
01.11.2012Renewal fee patent year 04
30.10.2013Renewal fee patent year 05
30.04.2015Renewal fee patent year 06
30.10.2015Renewal fee patent year 07
18.10.2016Renewal fee patent year 08
26.10.2017Renewal fee patent year 09
18.10.2018Renewal fee patent year 10
28.10.2019Renewal fee patent year 11
09.10.2020Renewal fee patent year 12
27.10.2021Renewal fee patent year 13
27.10.2022Renewal fee patent year 14
Penalty fee
Additional fee for renewal fee
31.10.201204   M06   Fee paid on   01.11.2012
31.10.201406   M06   Fee paid on   30.04.2015
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT28.12.2022
CZ28.12.2022
DK28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
MC28.12.2022
PL28.12.2022
RO28.12.2022
SE28.12.2022
SI28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
IS28.04.2023
PT28.04.2023
[2024/28]
Former [2024/11]AT28.12.2022
CZ28.12.2022
DK28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
PL28.12.2022
RO28.12.2022
SE28.12.2022
SI28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
IS28.04.2023
PT28.04.2023
Former [2023/46]AT28.12.2022
CZ28.12.2022
DK28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
PL28.12.2022
RO28.12.2022
SE28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
IS28.04.2023
PT28.04.2023
Former [2023/39]AT28.12.2022
CZ28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
PL28.12.2022
RO28.12.2022
SE28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
IS28.04.2023
PT28.04.2023
Former [2023/38]AT28.12.2022
CZ28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
PL28.12.2022
RO28.12.2022
SE28.12.2022
SK28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
PT28.04.2023
Former [2023/35]AT28.12.2022
CZ28.12.2022
EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
RO28.12.2022
SE28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
PT28.04.2023
Former [2023/34]EE28.12.2022
ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
SE28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
PT28.04.2023
Former [2023/33]ES28.12.2022
FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
SE28.12.2022
SM28.12.2022
NO28.03.2023
GR29.03.2023
Former [2023/24]FI28.12.2022
HR28.12.2022
LT28.12.2022
LV28.12.2022
SE28.12.2022
NO28.03.2023
GR29.03.2023
Former [2023/23]FI28.12.2022
LT28.12.2022
LV28.12.2022
SE28.12.2022
NO28.03.2023
GR29.03.2023
Former [2023/22]FI28.12.2022
LT28.12.2022
SE28.12.2022
NO28.03.2023
Former [2023/20]LT28.12.2022
NO28.03.2023
Documents cited:Search[X]WO2006105448  (MINERVA BIOTECHNOLOGIES CORP [US], et al) [X] 1-5,7 * claims 1,5-16 *;
 [E]WO2010042562  (MINERVA BIOTECHNOLOGIES CORP [US], et al) [E] 1-7 * the whole document *;
 [E]WO2010144887  (MINERVA BIOTECHNOLOGIES CORP [US], et al) [E] 1-7 * the whole document *;
 [X]  - HIKITA SHERRY T ET AL, "MUC1* mediates the growth of human pluripotent stem cells", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, US, (20081003), vol. 3, no. 10, doi:10.1371/JOURNAL.PONE.0003312, ISSN 1932-6203, page E3312, XP002560322 [X] 1-5,7 * the whole document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0003312
 [T]  - BENOIT J. SMAGGHE ET AL, "MUC1* Ligand, NM23-H1, Is a Novel Growth Factor That Maintains Human Stem Cells in a More Naïve State", PLOS ONE, (20130307), vol. 8, no. 3, doi:10.1371/journal.pone.0058601, page e58601, XP055058843

DOI:   http://dx.doi.org/10.1371/journal.pone.0058601
International search[X]US2006222637  (BAMDAD CYNTHIA C [US]);
 [Y]WO2008070171  (MINERVA BIOTECHNOLOGIES CORP [US], et al);
 [Y]  - THATHIAH A ET AL., "Tumor Necrosis factor-alpha Converting Enzyme/ADAM 17 Mediates MUC1 Shedding", J. BIOL. CHEM., (20030131), vol. 278, pages 3386 - 3394, XP003006375

DOI:   http://dx.doi.org/10.1074/jbc.M208326200
 [Y]  - BOYER LAURIE A ET AL., "Core transcriptional regulatory circuitry in human embryonic stem cells", (20050923), vol. 122, pages 947 - 956, XP002412923

DOI:   http://dx.doi.org/10.1016/j.cell.2005.08.020
by applicant   - AOI, T. et al., Science, (20080000), vol. 321, pages 699 - 702
    - BOYER L. A. et al., Cell, (20050000), vol. 122, pages 947 - 956
    - DEXHEIMER, Mol Cancer Ther, (20090000), vol. 8, pages 1363 - 1377
    - FESSLER S. et al., Cancer Res Treat. May, (20090000), vol. 5
    - FOSTER, K. W. et al., Oncogene, (20050000), vol. 24, pages 1491 - 1500
    - HIKITA et al., PLoS ONE, (20080000), vol. 3, page e3312
    - HUANG, L. et al., Cancer Res., (20050000), vol. 65, no. 22, pages 10413 - 22
    - HUANGFU D. et al., Nat Biotechnol, (20080000), vol. 26, pages 795 - 797
    - HUANGFU D. et al., Nat Biotechnol, (20080000), vol. 26, pages 1269 - 1275
    - JAENISCH, R.; YOUNG, R., Cell, (20080000), vol. 132, pages 567 - 582
    - KAJI K. et al., Nature, (20090000), vol. 458, pages 771 - 775
    - KAWAMURA et al., Nature, (20090000), vol. 460, no. 7259, pages 1140 - 4
    - KIM et al., Biochem Biophys Res Commun, (20030000), vol. 307, pages 281 - 289
    - KOMAROV et al., Science, (19990000), vol. 285, no. 5434, pages 1733 - 7
    - LIN T et al., Nat Cell Biol, (20050000), vol. 7, pages 165 - 171
    - LOWRY, W.E. et al., Proc. Natl. Acad. Sci. USA, (20080000), vol. 105, pages 2883 - 2888
    - LYSSIOTIS et al., Proc Natl Acad Sci USA, (20090000), vol. 106, pages 8912 - 8917
    - MAHANTA et al., PLoS ONE, (20080000), vol. 3, page e2054
    - MAHERALI, N. et al., Cell Stem Cell, (20070000), vol. 1, pages 55 - 70
    - MAIMTES T et al., Oncogene, (20080000), vol. 27, pages 5277 - 5287
    - NAKAGAWA, M. et al., Nature Biotechnol, (20080000), vol. 26, pages 101 - 106
    - OKITA, K et al., Nature, (20070000), vol. 448, pages 313 - 317
    - OKITA K et al., Science, (20090000), vol. 322, pages 949 - 953
    - PARK, I.H. et al., Nature, (20080000), vol. 451, pages 141 - 146
    - RAINA et al., Cancer Res, (20090000), vol. 69, pages 5133 - 5141
    - SOLDNER F. et al., Cell, (20090000), vol. 136, pages 964 - 977
    - SOMMER C A et al., Stem Cells, (20090000), vol. 27, no. 3, pages 543 - 9
    - STADTFELD M. et al., Science, (20090000), vol. 322, pages 945 - 949
    - STROM et al., Nat Chem Biol., (20060000), vol. 2, no. 9, pages 474 - 9
    - TAKAHASHI, K.; YAMANAKA, S., Cell, (20060000), vol. 126, pages 663 - 676
    - TAKAHASHI, K. et al., Cell, (20070000), vol. 131, pages 861 - 872
    - THATHIAH, A et al., J Biol Chem, (20030000), vol. 274, pages 3386 - 3394
    - VASSILEV L. T. et al., Science, (20040000), vol. 303, pages 844 - 848
    - WEI et al., Cancer Res, (20070000), vol. 67, pages 1853 - 1858
    - WERNIG, M. et al., Nature, (20070000), vol. 448, pages 318 - 324
    - WERNIG M. et al., Cell Stem Cell, (20080000), vol. 2, pages 10 - 12
    - WOLTJEN K. et al., Nature, (20090000), vol. 458, pages 766 - 770
    - YAMANAKA, S., Cell stem Cells, (20070000), vol. 1, pages 39 - 49
    - YU J. et al., Science, (20090000), vol. 324, pages 797 - 801
    - YU, J. et al., Science, (20070000), vol. 318, pages 1917 - 1920
    - ZHOU et al., MCB, (20000000), vol. 20, pages 628 - 633
    - ZHOU et al., Cell Stem Cell, (20090000), vol. 4, pages 381 - 384
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.